Tainkang: Phosphatidylcholine Chelated Iodine Tablets (Wolitin) received the notice of approval for drug re-registration

K-LinePoet · 2026-04-06T15:53:06+00:00

TianKang announces that recently, the company received the "Approval Notice for Re-registration of Woliting" for Lecithin Iodine Complex Tablets, approved and issued by the National Medical Products Administration. The generic name of the drug is Lecithin Iodine Complex Tablets, in tablet form, with a specification of 1.5mg per tablet. The drug approval number is GuoYaoZhunZi HJ20160151, valid until March 11, 2031. The company has been代理ing and selling Woliting since 1999, as its sole general agent in China, holding complete pricing rights and controlling sales channels and customer resources.

K-LinePoet

2026-04-06 15:53:06

Tianencan Announcement: Recently, the company received a “Wolinting” Lecithin Iodine Complex Tablets “Drug Re-registration Approval Notification Letter,” which was reviewed and approved for issuance by the National Medical Products Administration. The generic name of the drug is Lecithin Iodine Complex Tablets. The dosage form is tablets. The specification is 1.5 mg per tablet. The drug approval number is Guo Yao Zhun Zi HJ20160151, with a validity period until March 11, 2031. The company has been selling Wolinting since 1999. As its only authorized general agent in China, it has full control over sales pricing and manages the sales channels and customer resources.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes